floxuridine has been researched along with Biliary Tract Diseases in 2 studies
Floxuridine: An antineoplastic antimetabolite that is metabolized to fluorouracil when administered by rapid injection; when administered by slow, continuous, intra-arterial infusion, it is converted to floxuridine monophosphate. It has been used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.
floxuridine : A pyrimidine 2'-deoxyribonucleoside compound having 5-fluorouracil as the nucleobase; used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.
Biliary Tract Diseases: Diseases in any part of the BILIARY TRACT including the BILE DUCTS and the GALLBLADDER.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The goals of this study of a hepatic arterial infusion (HAI) regimen of alternating floxuridine and 5-fluorouracil were to evaluate the treatment-related toxic effects, the antitumor response rate, and patient survival." | 1.29 | Alternating floxuridine and 5-fluorouracil hepatic arterial chemotherapy for colorectal liver metastases minimizes biliary toxicity. ( Chase, JL; Curley, SA; Davidson, BS; DuBrow, RA; Hohn, DC; Izzo, F; Patt, Y, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ito, K | 1 |
| Ito, H | 1 |
| Kemeny, NE | 1 |
| Gonen, M | 1 |
| Allen, PJ | 1 |
| Paty, PB | 1 |
| Fong, Y | 1 |
| Dematteo, RP | 1 |
| Blumgart, LH | 1 |
| Jarnagin, WR | 1 |
| D'Angelica, MI | 1 |
| Davidson, BS | 1 |
| Izzo, F | 1 |
| Chase, JL | 1 |
| DuBrow, RA | 1 |
| Patt, Y | 1 |
| Hohn, DC | 1 |
| Curley, SA | 1 |
2 other studies available for floxuridine and Biliary Tract Diseases
| Article | Year |
|---|---|
Biliary sclerosis after hepatic arterial infusion pump chemotherapy for patients with colorectal cancer liver metastasis: incidence, clinical features, and risk factors.
Topics: Adult; Aged; Aged, 80 and over; Biliary Tract Diseases; Causality; Cohort Studies; Colorectal Neopla | 2012 |
Alternating floxuridine and 5-fluorouracil hepatic arterial chemotherapy for colorectal liver metastases minimizes biliary toxicity.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Biliar | 1996 |